S.)

Autogenous arteriovenous (AV) access for hemodialysis has been shown to be superior to prosthetic graft or
catheter access in terms of patient morbidity and mortality.
In addition, the maintenance of autogenous AV access is
less expensive than prosthetic conduits.1-5 Although several
reports have shown an autogenous AV access is feasible in
most patients in the United States, construction and utilization rates for autogenous AV access for hemodialysis in